8th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress 2012

TheMetabolic Syndrome, type II Diabetes and Atherosclerosis Congress brings together cardiologists, diabetologists and scientists to discuss therapeutic managements and prevention of type II Diabetes, Metabolic Syndrome and Atherosclerosis.

Key Topics

• Metabolic syndrome: risk factors and pharmacotherapy
• Role in chronic diseases diabetes as a model
• Prevalence of metabolic syndrome in Middle East
• Pharmacotherapy for the management of metabolic syndrome
• Hypertriglyceridemia: therapeutic challenges
• Management of HDL-C in patients with diabetes and metabolic syndrome
• Pathogenesis and risk factors for atrial fibrillation
• Prevention of the vascular complications of diabetes type II
• Triglycerides, HDL-C and the risk of coronary disease
• Primary and secondary prevention of stroke in atrial fibrillation
• The risk versus benefits of standard and emerging antiplatelet therapies
• Hypertension and CV risk reduction in patients with diabetes
• Metabolic syndrome, diabetes and their complications
• Advances in the clinical management of lipids and glucose for the prevention of CVD in metabolic diseases